AIM: The aim of this study is to determine the prevalence and evolution of anaemia in prospectively followed children and adolescents diagnosed with Crohn's disease (CD). METHODS: The BELCRO registry (inclusion May 2008-April 2010), describing current clinical treatment practice of children diagnosed with CD, provided data on age, height, body mass index (BMI), paediatric Crohn's disease activity index (PCDAI), therapy and haemoglobin (Hb) at diagnosis 12 and 24 months follow-up. Anaemia was defined as Hb < -2 sd, while severe anaemia was defined as Hb < -4 sd. Patients were classified as child ≤13 and adolescent >13 years of age. RESULT: Ninety-six were included, 13 dropped out due to insufficient Hb data (37 females/46 males; median age 13.3 years, range 2.2-17.8 years). At diagnosis, the median Hb sd was -2.66 (-8.4; 1.07) and was correlated with the PCDAI (p = 0.013). At diagnosis, 51/83 (61%) were anaemic and all had active disease. Hb z-score significantly improved (p < 0.0001) but 26/68 (38%) remained anaemic at 12 months and 29/76 (38%) at 24 months of follow-up. The correlation to the PCDAI disappeared. At 24 months, children were more likely to be anaemic. There was no difference in iron dose nor duration of iron supplements between children and adolescents. Iron treatment was more readily given to patients presenting with anaemia. Hb did not differ between patients with (n = 28) or without iron supplements. Half of the patients with persisting anaemia were given iron supplements, of which, only three were given intravenously. CONCLUSION: Anaemia remains an important extra-intestinal manifestation of CD in children. Physicians, lacking optimal treatment strategies, undertreat their patients.
AIM: The aim of this study is to determine the prevalence and evolution of anaemia in prospectively followed children and adolescents diagnosed with Crohn's disease (CD). METHODS: The BELCRO registry (inclusion May 2008-April 2010), describing current clinical treatment practice of children diagnosed with CD, provided data on age, height, body mass index (BMI), paediatric Crohn's disease activity index (PCDAI), therapy and haemoglobin (Hb) at diagnosis 12 and 24 months follow-up. Anaemia was defined as Hb < -2 sd, while severe anaemia was defined as Hb < -4 sd. Patients were classified as child ≤13 and adolescent >13 years of age. RESULT: Ninety-six were included, 13 dropped out due to insufficient Hb data (37 females/46 males; median age 13.3 years, range 2.2-17.8 years). At diagnosis, the median Hb sd was -2.66 (-8.4; 1.07) and was correlated with the PCDAI (p = 0.013). At diagnosis, 51/83 (61%) were anaemic and all had active disease. Hb z-score significantly improved (p < 0.0001) but 26/68 (38%) remained anaemic at 12 months and 29/76 (38%) at 24 months of follow-up. The correlation to the PCDAI disappeared. At 24 months, children were more likely to be anaemic. There was no difference in iron dose nor duration of iron supplements between children and adolescents. Iron treatment was more readily given to patients presenting with anaemia. Hb did not differ between patients with (n = 28) or without iron supplements. Half of the patients with persisting anaemia were given iron supplements, of which, only three were given intravenously. CONCLUSION:Anaemia remains an important extra-intestinal manifestation of CD in children. Physicians, lacking optimal treatment strategies, undertreat their patients.
Authors: Thomas W Lee; Michael R Kolber; Richard N Fedorak; Sander Veldhuyzen van Zanten Journal: J Crohns Colitis Date: 2011-10-26 Impact factor: 9.071
Authors: Lise P M Pels; Els Van de Vijver; Herman J Waalkens; Jan Uitentuis; Gieneke JGonera-de ong; Lidy A T van Overbeek; Obbe F Norbruis; Edmond H H M Rings; Patrick F van Rheenen Journal: J Pediatr Gastroenterol Nutr Date: 2010-12 Impact factor: 2.839
Authors: Christoph Gasche; Arnold Berstad; Ragnar Befrits; Christoph Beglinger; Axel Dignass; Kari Erichsen; Fernando Gomollon; Henrik Hjortswang; Ioannis Koutroubakis; Stefanie Kulnigg; Bas Oldenburg; David Rampton; Oliver Schroeder; Jürgen Stein; Simon Travis; Gert Van Assche Journal: Inflamm Bowel Dis Date: 2007-12 Impact factor: 5.325
Authors: Javier P Gisbert; Fernando Bermejo; Ramón Pajares; Jose-Lázaro Pérez-Calle; María Rodríguez; Alicia Algaba; Noemí Mancenido; Felipe de la Morena; Jose Antonio Carneros; Adrián G McNicholl; Yago González-Lama; José Maté Journal: Inflamm Bowel Dis Date: 2009-10 Impact factor: 5.325
Authors: E De Greef; J M Mahachie John; I Hoffman; F Smets; S Van Biervliet; M Scaillon; B Hauser; I Paquot; P Alliet; W Arts; O Dewit; H Peeters; F Baert; G D'Haens; J F Rahier; I Etienne; O Bauraind; A Van Gossum; S Vermeire; F Fontaine; V Muls; E Louis; F Van de Mierop; J C Coche; K Van Steen; G Veereman Journal: J Crohns Colitis Date: 2013-05-09 Impact factor: 9.071
Authors: Steven D Miller; Carmelo Cuffari; Eboselume Akhuemonkhan; Anthony L Guerrerio; Harold Lehmann; Susan Hutfless Journal: Pediatr Gastroenterol Hepatol Nutr Date: 2019-02-27